These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 39389599)

  • 1. Correlation of the treatment sensitivity of patient-derived organoids with treatment outcomes in patients with head and neck cancer (SOTO): protocol for a prospective observational study.
    Vasiliadou I; Cattaneo C; Chan PYK; Henley-Smith R; Gregson-Williams H; Collins L; Wojewodka G; Guerrero-Urbano T; Jeannon JP; Connor S; Davis J; Pasto A; Mustapha R; Ng T; Kong A
    BMJ Open; 2024 Oct; 14(10):e084176. PubMed ID: 39389599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ORGAVADS: establishment of tumor organoids from head and neck squamous cell carcinoma to assess their response to innovative therapies.
    Perréard M; Florent R; Divoux J; Grellard JM; Lequesne J; Briand M; Clarisse B; Rousseau N; Lebreton E; Dubois B; Harter V; Lasne-Cardon A; Drouet J; Johnson A; Le Page AL; Bazille C; Jeanne C; Figeac M; Goardon N; Vaur D; Micault E; Humbert M; Thariat J; Babin E; Poulain L; Weiswald LB; Bastit V
    BMC Cancer; 2023 Mar; 23(1):223. PubMed ID: 36894916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinicopathological Factors as Predictors for Establishment of Patient Derived Head and Neck Squamous Cell Carcinoma Organoids.
    de Kort WWB; Millen R; Driehuis E; Devriese LA; van Es RJJ; Willems SM
    Head Neck Pathol; 2024 Jun; 18(1):59. PubMed ID: 38940869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Head and neck cancer organoids established by modification of the CTOS method can be used to predict in vivo drug sensitivity.
    Tanaka N; Osman AA; Takahashi Y; Lindemann A; Patel AA; Zhao M; Takahashi H; Myers JN
    Oral Oncol; 2018 Dec; 87():49-57. PubMed ID: 30527243
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Joseph S; Janakiraman R; Chacko G; Jayaraj R; Thomas M; Thomas M; Mukhopadhyay S
    BMJ Open; 2017 Oct; 7(10):e014824. PubMed ID: 29038175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The molecular characteristics of recurrent/metastatic HPV-positive head and neck squamous cell carcinoma: A systematic review of the literature.
    Flach S; Maniam P; Hey SY; Manickavasagam J
    Clin Otolaryngol; 2024 Jul; 49(4):384-403. PubMed ID: 38658385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral Mucosal Organoids as a Potential Platform for Personalized Cancer Therapy.
    Driehuis E; Kolders S; Spelier S; Lõhmussaar K; Willems SM; Devriese LA; de Bree R; de Ruiter EJ; Korving J; Begthel H; van Es JH; Geurts V; He GW; van Jaarsveld RH; Oka R; Muraro MJ; Vivié J; Zandvliet MMJM; Hendrickx APA; Iakobachvili N; Sridevi P; Kranenburg O; van Boxtel R; Kops GJPL; Tuveson DA; Peters PJ; van Oudenaarden A; Clevers H
    Cancer Discov; 2019 Jul; 9(7):852-871. PubMed ID: 31053628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase I trial of WEE1 inhibition with chemotherapy and radiotherapy as adjuvant treatment, and a window of opportunity trial with cisplatin in patients with head and neck cancer: the
    Kong A; Good J; Kirkham A; Savage J; Mant R; Llewellyn L; Parish J; Spruce R; Forster M; Schipani S; Harrington K; Sacco J; Murray P; Middleton G; Yap C; Mehanna H
    BMJ Open; 2020 Mar; 10(3):e033009. PubMed ID: 32184305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protocol for the EACH trial: a multicentre phase II study evaluating the safety and antitumour activity of the combination of avelumab, an anti-PD-L1 agent, and cetuximab, as any line treatment for patients with recurrent/metastatic head and neck squamous cell cancer (HNSCC) in the UK.
    Ng K; Metcalf R; Sacco J; Kong A; Wheeler G; Forsyth S; Bhat R; Ward J; Ensell L; Lowe H; Spanswick V; Hartley J; White L; Lloyd-Dehler E; Forster M
    BMJ Open; 2023 Nov; 13(11):e070391. PubMed ID: 38011968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The COMPLETE trial: HolistiC early respOnse assessMent for oroPharyngeaL cancEr paTiEnts; Protocol for an observational study.
    Verduijn GM; Capala ME; Sijtsema ND; Lauwers I; Hernandez Tamames JA; Heemsbergen WD; Sewnaik A; Hardillo JA; Mast H; van Norden Y; Jansen MPHM; van der Lugt A; van Gent DC; Hoogeman MS; Mostert B; Petit SF
    BMJ Open; 2022 May; 12(5):e059345. PubMed ID: 35584883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Afatinib versus placebo as adjuvant therapy after chemoradiation in a double-blind, phase III study (LUX-Head & Neck 2) in patients with primary unresected, clinically intermediate-to-high-risk head and neck cancer: study protocol for a randomized controlled trial.
    Burtness B; Bourhis JP; Vermorken JB; Harrington KJ; Cohen EE
    Trials; 2014 Nov; 15():469. PubMed ID: 25432788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Definitive chemoradiotherapy in patients with squamous cell cancers of the head and neck - results from an unselected cohort of the clinical cooperation group "Personalized Radiotherapy in Head and Neck Cancer".
    Schüttrumpf L; Marschner S; Scheu K; Hess J; Rietzler S; Walch A; Baumeister P; Kirchner T; Ganswindt U; Zitzelsberger H; Belka C; Maihoefer C
    Radiat Oncol; 2020 Jan; 15(1):7. PubMed ID: 31906998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The organoid as reliable cancer modeling in personalized medicine, does applicable in precision medicine of head and neck squamous cell carcinoma?
    Farshbaf A; Lotfi M; Zare R; Mohtasham N
    Pharmacogenomics J; 2023 May; 23(2-3):37-44. PubMed ID: 36347937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single-Cell Molecular Profiling of Head and Neck Squamous Cell Carcinoma Reveals Five Dysregulated Signaling Pathways Associated With Circulating Tumor Cells.
    Stucky A; Viet CT; Aouizerat BE; Ye Y; Doan C; Mundluru T; Sedhiazadeh P; Sinha UK; Chen X; Zhang X; Li SC; Cai J; Zhong JF
    Cancer Control; 2024; 31():10732748241251571. PubMed ID: 38869038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Feasibility analysis of using patient-derived tumour organoids for treatment decision guidance in locally advanced head and neck squamous cell carcinoma.
    Fisch AS; Pestana A; Sachse V; Doll C; Hofmann E; Heiland M; Obermueller T; Heidemann J; Dommerich S; Schoppe D; Schallenberg S; Piwonski I; Blanc E; Tinhofer I
    Eur J Cancer; 2024 Dec; 213():115100. PubMed ID: 39476443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ovarian cancer-derived copy number alterations signatures are prognostic in chemoradiotherapy-treated head and neck squamous cell carcinoma.
    Essers PBM; van der Heijden M; Vossen D; de Roest RH; Leemans CR; Brakenhoff RH; van den Brekel MWM; Bartelink H; Verheij M; Vens C
    Int J Cancer; 2020 Sep; 147(6):1732-1739. PubMed ID: 32167160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating Tumour Cell Expression of Immune Markers as Prognostic and Therapeutic Biomarkers in Head and Neck Squamous Cell Carcinoma: A Systematic Review and Meta-Analysis.
    Payne K; Pugh M; Brooks J; Batis N; Taylor G; Nankivell P; Mehanna H
    Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33153130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predicting progression-free survival after systemic therapy in advanced head and neck cancer: Bayesian regression and model development.
    Barber PR; Mustapha R; Flores-Borja F; Alfano G; Ng K; Weitsman G; Dolcetti L; Suwaidan AA; Wong F; Vicencio JM; Galazi M; Opzoomer JW; Arnold JN; Thavaraj S; Kordasti S; Doyle J; Greenberg J; Dillon MT; Harrington KJ; Forster M; Coolen ACC; Ng T
    Elife; 2022 Dec; 11():. PubMed ID: 36562609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insights into metastatic roadmap of head and neck cancer squamous cell carcinoma based on clinical, histopathological and molecular profiles.
    Mastronikolis NS; Delides A; Kyrodimos E; Piperigkou Z; Spyropoulou D; Giotakis E; Tsiambas E; Karamanos NK
    Mol Biol Rep; 2024 Apr; 51(1):597. PubMed ID: 38683372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.